Patent intelligence · US
US 8969571
Biphenyl derivatives
Biphenyl derivatives
Patent details — US 8969571
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 3, 2015
- Expiration
- Feb 26, 2035
- Applicant
- Theravance Respiratory Company, LLC
- Claims
- 3
- CPC classes
- A61K, A61K31/445, A61K31/452, A61P
Quick answer
US 8969571 (Biphenyl derivatives) is held by Theravance Respiratory Company, LLC. Status: granted. Granted Mar 3, 2015. Expires Feb 26, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Theravance Respiratory Company, LLC
- Grant date
- Expiration
- Claims
- 3
- CPC classes
- A61K, A61K31/445, A61K31/452, A61P, A61P11/00, A61P11/06
More from Theravance Respiratory Company, LLC
Related pharmaceutical patents in our USPTO index.
-
US 12384761
Imidazolo indazole compounds as JAK inhibitors
granted -
US 12358931
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor
granted -
US 12351561
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
granted -
US 12285417
Methods for treating chronic obstructive pulmonary disease
granted -
US 12258316
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 12239638
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
granted -
US 12172994
Pyrimidine compound as JAK kinase inhibitor
granted -
US 12122773
Crystalline hydrate of a JAK inhibitor compound
granted
Frequently asked questions
What is US patent 8969571?
US 8969571 (Biphenyl derivatives) is held by Theravance Respiratory Company, LLC. Status: granted. Granted Mar 3, 2015. Expires Feb 26, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8969571?
Theravance Respiratory Company, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 635 pharmaceutical patents for this assignee.
When does US 8969571 expire?
Our index shows an expiration date of Feb 26, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.